Cargando…

PLK1‐dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV‐infected mice

While Epstein–Barr virus (EBV) establishes a life‐long latent infection in apparently healthy human immunocompetent hosts, immunodeficient individuals are at particular risk to develop lymphoproliferative B‐cell malignancies caused by EBV. A key EBV protein is the transcription factor EBV nuclear an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiang, Schuhmachers, Patrick, Mourão, André, Giansanti, Piero, Murer, Anita, Thumann, Sybille, Kuklik‐Roos, Cornelia, Beer, Sophie, Hauck, Stefanie M, Hammerschmidt, Wolfgang, Küppers, Ralf, Kuster, Bernhard, Raab, Monika, Strebhardt, Klaus, Sattler, Michael, Münz, Christian, Kempkes, Bettina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647151/ https://www.ncbi.nlm.nih.gov/pubmed/34605140 http://dx.doi.org/10.15252/embr.202153007

Ejemplares similares

Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice
por: Schuhmachers, Patrick, et al.
Publicado: (2021)

EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells
por: Glaser, Laura V., et al.
Publicado: (2017)

The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation
por: Friberg, Anders, et al.
Publicado: (2015)

Role of EBNA-3 Family Proteins in EBV Associated B-cell Lymphomagenesis
por: Bhattacharjee, Shaoni, et al.
Publicado: (2016)

EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus–infected B cells
por: Beer, Sophie, et al.
Publicado: (2022)

EBV persistence without its EBNA3A and 3C oncogenes in vivo
por: Murer, Anita, et al.
Publicado: (2018)

EBV and Lymphomagenesis
por: Sausen, Daniel G., et al.
Publicado: (2023)

Quantitative chemical proteomics reveals a Plk1 inhibitor-compromised cell death pathway in human cells
por: Raab, Monika, et al.
Publicado: (2014)

Immune adaptor SKAP1 acts a scaffold for Polo-like kinase 1 (PLK1) for the optimal cell cycling of T-cells
por: Raab, Monika, et al.
Publicado: (2019)

A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1
por: Raab, Monika, et al.
Publicado: (2021)

The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses
por: Münz, Christian
Publicado: (2021)

Correction: A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1
por: Raab, Monika, et al.
Publicado: (2023)

Differential Gene Expression Patterns of EBV Infected EBNA-3A Positive and Negative Human B Lymphocytes
por: Hertle, Marie L., et al.
Publicado: (2009)

Bhlhe40 function in activated B and T(FH) cells restrains the GC reaction and prevents lymphomagenesis
por: Rauschmeier, René, et al.
Publicado: (2021)

EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells
por: Kalchschmidt, Jens S., et al.
Publicado: (2016)

Role of Specific B-Cell Receptor Antigens in Lymphomagenesis
por: Thurner, Lorenz, et al.
Publicado: (2020)

Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8
por: Helmke, Christina, et al.
Publicado: (2016)

Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis
por: Ghosh Roy, Shatadru, et al.
Publicado: (2016)

PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells
por: Raab, Monika, et al.
Publicado: (2018)

Immunosenescence and lymphomagenesis
por: Mancuso, Salvatrice, et al.
Publicado: (2018)

The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis
por: Mintz, Michelle A., et al.
Publicado: (2019)

Gata3 restrains B cell proliferation and cooperates with p18(INK4c) to repress B cell lymphomagenesis
por: Liu, Shiqin, et al.
Publicado: (2016)

Sequential Targeting of PLK1 and PARP1 Reverses the Resistance to PARP Inhibitors and Enhances Platin-Based Chemotherapy in BRCA-Deficient High-Grade Serous Ovarian Cancer with KRAS Amplification
por: Gasimli, Khayal, et al.
Publicado: (2022)

The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency
por: Styles, Christine T., et al.
Publicado: (2018)

Virus-Associated Lymphomagenesis
por: Tarantul, V. Z.
Publicado: (2006)

The Prognostic Relevance of the Proliferation Markers Ki-67 and Plk1 in Early-Stage Ovarian Cancer Patients With Serous, Low-Grade Carcinoma Based on mRNA and Protein Expression
por: Rödel, Franz, et al.
Publicado: (2020)

Targeted disruption of EBNA1 in EBV-infected cells attenuated cell growth
por: Noh, Ka-Won, et al.
Publicado: (2016)

ERK2 phosphorylation of EBNA1 serine 383 residue is important for EBNA1-dependent transactivation
por: Noh, Ka-Won, et al.
Publicado: (2016)

Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA
por: Yadav, Pragya, et al.
Publicado: (2016)

Lymphomagenesis predictors and related pathogenesis
por: Ruiz-Ordoñez, Ingrid, et al.
Publicado: (2021)

Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis
por: Saleem, Atif, et al.
Publicado: (2020)

A STING inhibitor suppresses EBV‐induced B cell transformation and lymphomagenesis
por: Miyagi, Shouhei, et al.
Publicado: (2021)

Modulation of alternative splicing during early infection of human primary B lymphocytes with Epstein-Barr virus (EBV): a novel function for the viral EBNA-LP protein
por: Manet, Evelyne, et al.
Publicado: (2021)

BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV
por: Paschos, Kostas, et al.
Publicado: (2012)

Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2 Among Vietnamese Patients with Nasopharyngeal Brush Samples
por: Lao, Thuan Duc, et al.
Publicado: (2017)

Erratum for Murer et al., “MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo”
por: Murer, Anita, et al.
Publicado: (2019)

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo
por: Murer, Anita, et al.
Publicado: (2019)

Inactivation of Intergenic Enhancers by EBNA3A Initiates and Maintains Polycomb Signatures across a Chromatin Domain Encoding CXCL10 and CXCL9
por: Harth-Hertle, Marie L., et al.
Publicado: (2013)

Murine Cytotoxic T Lymphocytes Recognize an Epitope in an EBNA-1 Fragment, but Fail to Lyse EBNA-1–expressing Mouse Cells
por: Mukherjee, Siddhartha, et al.
Publicado: (1998)

Abelson virus-induced lymphomagenesis in mice
Publicado: (1978)

Cannot write session to /tmp/vufind_sessions/sess_rogh7633aqk6aljkvmn0aok5h1